JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q2 2019 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ)
Q2 2019 Results Earnings Conference Call
August 06, 2019, 04:30 PM ET
Company Participants
Katherine Littrell - Vice President, Investor Relations
Bruce Cozadd - Chairman and Chief Executive Officer
Rob Iannone - Executive Vice President, R&D
Matthew Young - Executive Vice President and Chief Financial Officer
Daniel Swisher - President and COO
Mike Miller - Executive Vice President, U.S. Commercial
Matt Young - EVP and CFO
Allen Yang - Senior Vice President Clinical Development and Acting CMO
Conference Call Participants
Ami Fadia - SVB Leerink
Akash Tewari - Wolfe Research
Jessica